Weiss Multi-Strategy Advisers’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-15,051	Closed	-$142K	–	781
2020 Q3	$142K	Sell	15,051 -3,941	-21%	-$42.6K	﹤0.01%	537
2020 Q2	$170K	Buy	18,992 +648	+4%	+$6.01K	﹤0.01%	522
2020 Q1	$117K	Sell	18,344 -11,656	-39%	-$86.5K	﹤0.01%	399
2019 Q4	$251K	Hold	30,000	–	–	﹤0.01%	569
2019 Q3	$272K	Hold	30,000	–	–	0.01%	526
2019 Q2	$323K	Buy	+30,000	New	+$319K	0.01%	448
2018 Q2	–	Sell	-10,000	Closed	-$190K	–	662
2018 Q1	$190K	Sell	10,000 -20,000	-67%	-$428K	0.01%	506
2017 Q4	$492K	Sell	30,000 -20,000	-40%	-$298K	0.01%	495
2017 Q3	$750K	Sell	50,000 -25,000	-33%	-$276K	0.03%	402
2017 Q2	$660K	Sell	75,000 -10,000	-12%	-$64.2K	0.03%	412
2017 Q1	$442K	Hold	85,000	–	–	0.02%	455
2016 Q4	$259K	Hold	85,000	–	–	0.01%	370
2016 Q3	$394K	Buy	85,000 +52,195	+159%	+$265K	0.02%	356
2016 Q2	$190K	Buy	+32,805	New	+$209K	0.01%	378
2014 Q2	–	Sell	-12,500	Closed	-$226K	–	899
2014 Q1	$226K	Sell	12,500 -570	-4%	-$11K	﹤0.01%	887
2013 Q4	$182K	Buy	+13,070	New	+$150K	﹤0.01%	916

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Weiss Multi-Strategy Advisers's SGMO Position: Q4 2020 in Review

Weiss Multi-Strategy Advisers sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q4 2020, closing a stake of 15,051 shares — an estimated $142K sold.

Weiss Multi-Strategy Advisers first reported a position in SGMO in Q4 2013 and held it in 16 quarters. The position peaked at $750K in Q3 2017. 223 funds tracked by Wall St. Rank hold SGMO as of Q4 2020.

Weiss Multi-Strategy Advisers reported no remaining SANGAMO THERAPEUTICS INC position as of Q4 2020 after selling out during the quarter.
Weiss Multi-Strategy Advisers sold 15,051 SANGAMO THERAPEUTICS INC shares in Q4 2020, an estimated $142K.
Weiss Multi-Strategy Advisers first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 16 quarters.
Weiss Multi-Strategy Advisers's SANGAMO THERAPEUTICS INC position peaked at $750K in Q3 2017.
223 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q4 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2020, filed 16 Feb 2021.